The Evolution of Topical PDE4 Inhibitors in Treating Atopic Dermatitis

home / dermview / the-evolution-of-topical-pde4-inhibitors-in-treating-atopic-dermatitis

Panelists discuss how advancements in topical PDE4 inhibitors, particularly roflumilast and crisaborole, are reshaping the management of atopic dermatitis by offering new nonsteroidal options with distinct mechanisms of action and safety profiles.

© 2024 MJH Life Sciences

All rights reserved.